Log In
Monday 21st May 2018

Milk scandal resurfaces in China

26th January 2010

According to China's official media, the country has still not rid itself of melamine-laced milk products.


It has been more than a year since the chemical was found to have caused at least six deaths and innumerable cases of kidney stones in Chinese infants across the country.

Elevated levels of the substance were found in products made by three food companies in Guizhou, a remote province in southwestern China.

Last year, when melamine was found in most Chinese dairy products and in its exports abroad, Chinese state media blamed it for the death of at least six infants and at about 300,000 illnesses.

Following the discovery of widespread milk tainting, Chinese dairy products made international headlines, and China's dairy exports were removed from stores and warehouses in many countries.

Two people were recently executed for their involvement in tainting Chinese milk with melamine in order to make it appear as if it had a high protein content.

Regarding the products still on shelves in Guizhou, China's state media said that the products were probably manufactured before the 2008 recall.

The recent discovery in Guizhou is not the first time after the 2008 recall that a company has been discovered distributing tainted milk.

A few weeks ago, a dairy in Shanghai which was closed down during the scandal for producing milk laced with the chemical was closed down again.

China's state media said that the three companies selling products in Guizhou, which is one of China's poorest provinces, were not located there.

The products they produced were manufactured several months ago, well after the government assured citizens that its products were clean.

Ling Hu, a Guizhou provincial spokeswoman, said that officials were aware of the situation, but could not say anything else.

Wang Dingmian, former chairman of the Guangdong Provincial Dairy Association, said that China's dairy problems were not yet totally solved.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018